Regeneron Pharmaceuticals faces a class action lawsuit for securities fraud over misleading claims about Fianlimab-Libtayo trial results. Shares are lower in after-hours trading.
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, ...
Un American Depositary Receipt (ADR) es un certificado emitido por un banco de inversión de EE. UU. que representa una cantidad de acciones (generalmente una acción) de una empresa extranjera, no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results